Atria Investments’s Journey Medical DERM Stock Holding History

Atria Investments’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84.5K	Sell	11,941 -2,510	-17%	-$14.3K	﹤0.01%	2095
2026 Q1	$67.8K	Buy	14,451 +1,374	+11%	+$10.7K	﹤0.01%	2019
2025 Q4	$101K	Sell	13,077 -12,553	-49%	-$98.4K	﹤0.01%	2003
2025 Q3	$182K	Sell	25,630 -11,555	-31%	-$83.8K	﹤0.01%	1962
2025 Q2	$267K	Sell	37,185 -7,474	-17%	-$51.7K	﹤0.01%	1776
2025 Q1	$263K	Buy	44,659 +1,214	+3%	+$5.97K	﹤0.01%	1694
2024 Q4	$170K	Sell	43,445 -952	-2%	-$5.2K	﹤0.01%	1806
2024 Q3	$251K	Sell	44,397 -10,940	-20%	-$56.3K	﹤0.01%	1708
2024 Q2	$312K	Buy	+55,337	New	+$228K	﹤0.01%	1563

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Atria Investments's DERM Position: Q2 2026 in Review

Atria Investments reduced its Journey Medical (DERM) stake by 17% in Q2 2026, selling an estimated $14.3K and leaving 11,941 shares worth $84.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2095.

Atria Investments first reported a position in DERM in Q2 2024 and has held it in 9 quarters since. The position peaked at $312K in Q2 2024. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Atria Investments held 11,941 shares of Journey Medical worth $84.5K as of Q2 2026.
Atria Investments sold 2,510 Journey Medical shares in Q2 2026, an estimated $14.3K.
Journey Medical made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #2095 holding.
Atria Investments first reported a position in Journey Medical in Q2 2024 and has held it in 9 quarters since.
Atria Investments's Journey Medical position peaked at $312K in Q2 2024.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.